Cargando…
Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review
BACKGROUND: Neurofibromatosis 1 (NF1) is the most common autosomal dominant disorder, with an incidence of 1 in 2,500-3,300 live births. NF1 is associated with significant morbidity and mortality because of complications, especially malignant peripheral nerve sheath tumors (MPNSTs), which mainly dev...
Autores principales: | Zehou, Ouidad, Fabre, Elizabeth, Zelek, Laurent, Sbidian, Emilie, Ortonne, Nicolas, Banu, Eugeniu, Wolkenstein, Pierre, Valeyrie-Allanore, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766199/ https://www.ncbi.nlm.nih.gov/pubmed/23972085 http://dx.doi.org/10.1186/1750-1172-8-127 |
Ejemplares similares
-
Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1
por: Van Der Gucht, Axel, et al.
Publicado: (2016) -
MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis
por: Masliah-Planchon, Julien, et al.
Publicado: (2013) -
Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study
por: Sbidian, Emilie, et al.
Publicado: (2012) -
Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966
por: Bergqvist, Christina, et al.
Publicado: (2020) -
Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
por: Duong, Tu Anh, et al.
Publicado: (2011)